Share Email Print
cover

Proceedings Paper

Quantitative label-free multimodality nonlinear optical imaging for in situ differentiation of cancerous lesions
Author(s): Xiaoyun Xu; Xiaoyan Li; Jie Cheng; Zhengfan Liu; Michael J. Thrall; Xi Wang; Zhiyong Wang; Stephen T. C. Wong
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The development of real-time, label-free imaging techniques has recently attracted research interest for in situ differentiation of cancerous lesions from normal tissues. Molecule-specific intrinsic contrast can arise from label-free imaging techniques such as Coherent Anti-Stokes Raman Scattering (CARS), Two-Photon Excited AutoFluorescence (TPEAF), and Second Harmonic Generation (SHG), which, in combination, would hold the promise of a powerful label-free tool for cancer diagnosis. Among cancer-related deaths, lung carcinoma is the leading cause for both sexes. Although early treatment can increase the survival rate dramatically, lesion detection and precise diagnosis at an early stage is unusual due to its asymptomatic nature and limitations of current diagnostic techniques that make screening difficult. We investigated the potential of using multimodality nonlinear optical microscopy that incorporates CARS, TPEAF, and SHG techniques for differentiation of lung cancer from normal tissue. Cancerous and non-cancerous lung tissue samples from patients were imaged using CARS, TPEAF, and SHG techniques for comparison. These images showed good pathology correlation with hematoxylin and eosin (H and E) stained sections from the same tissue samples. Ongoing work includes imaging at various penetration depths to show three-dimensional morphologies of tumor cell nuclei using CARS, elastin using TPEAF, and collagen using SHG and developing classification algorithms for quantitative feature extraction to enable lung cancer diagnosis. Our results indicate that via real-time morphology analyses, a multimodality nonlinear optical imaging platform potentially offers a powerful minimally-invasive way to differentiate cancer lesions from surrounding non-tumor tissues in vivo for clinical applications.

Paper Details

Date Published: 8 March 2013
PDF: 10 pages
Proc. SPIE 8565, Photonic Therapeutics and Diagnostics IX, 85653A (8 March 2013); doi: 10.1117/12.2002633
Show Author Affiliations
Xiaoyun Xu, The Methodist Hospital Research Institute (United States)
Xiaoyan Li, The Methodist Hospital Research Institute (United States)
Jie Cheng, The Methodist Hospital Research Institute (United States)
Zhengfan Liu, The Methodist Hospital Research Institute (United States)
Michael J. Thrall, The Methodist Hospital System (United States)
Xi Wang, The Methodist Hospital Research Institute (United States)
Zhiyong Wang, The Methodist Hospital Research Institute (United States)
Weill Cornell Medical College (United States)
Stephen T. C. Wong, The Methodist Hospital Research Institute (United States)
Weill Cornell Medical College (United States)


Published in SPIE Proceedings Vol. 8565:
Photonic Therapeutics and Diagnostics IX
Andreas Mandelis; Brian Jet-Fei Wong; Anita Mahadevan-Jansen; Henry Hirschberg M.D.; Hyun Wook Kang; Nikiforos Kollias; Melissa J. Suter; Kenton W. Gregory M.D.; Guillermo J. Tearney M.D.; Stephen Lam; Bernard Choi; Steen J. Madsen; Bodo E. Knudsen M.D.; E. Duco Jansen; Justus F. Ilgner M.D.; Haishan Zeng; Matthew Brenner; Laura Marcu, Editor(s)

© SPIE. Terms of Use
Back to Top
PREMIUM CONTENT
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?
close_icon_gray